GILD Financial Facts
Interest expense: -242MProduct sales: 7.41B
See Full Income Statement
Short-term marketable securities: 2.46B
Total assets: 56.61B
See Full Balance Sheet
Gilead Sciences Inc. (GILD) Earnings
|
Expand Research on GILD
| Next EPS Date | 4/25/24 | EPS Growth Rate | +16.1% |
|---|---|---|---|
| Average EPS % Beat Rate | -2.9% | Revenue Growth Rate | -0.6% |
| Average % Move 1-Wk after EPS | -3.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/24  |
Q124 | N/A | $1.59 | N/A | N/A | $6.36B | = | N/A | N/A | ||
| 2/1/22 |  |
Q421 | $0.69 | $1.52 | -$0.83 | $7.2B | $6.51B | = |  | | Details |
| 2/4/20 | |
Q419 | $1.30 | $1.67 | -$0.37 | $5.9B | $5.71B |  |
| | Details |
| 7/30/20 | |
Q220 | $1.11 | $1.45 | -$0.34 | $5.1B | $5.31B | |
| | Details |
| 8/3/23 | Q223 | $1.34 | $1.65 | -$0.31 | $6.6B | $6.45B | = | | | Details | |
| 2/4/19 | |
Q418 | $1.44 | $1.71 | -$0.27 | $5.8B | $5.49B | = | | | Details |
| 5/1/18 | |
Q118 | $1.48 | $1.67 | -$0.19 | $5.1B | $5.4B | = | | | Details |
| 4/27/23 | Q123 | $1.37 | $1.53 | -$0.16 | $6.4B | $6.31B | = | | | Details |
